Investor Relations Consulting Agreement Between Entest BioMedical Inc. And Synergy Business Consultants LLCInvestor Relations Consulting Agreement • April 3rd, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
Contract Type FiledApril 3rd, 2017 Company Industry JurisdictionThis document acts forth the agreement Entest BioMedical Inc. (“the Company”) and Synergy Business Consultants LLC concerning Investor Relation and Financial Public Relation services rendered to the Company from January 30, 2017 and continuing through February 30, 2017. (1 month).
ENTEST BIOMEDICAL,INC AND THOMAS E. ICHIM AGREEMENTPurchase Agreement • April 3rd, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations
Contract Type FiledApril 3rd, 2017 Company IndustryEntest Biomedical, Inc. agrees to purchase Regen BioPharma Inc.’s certificate #RA 576 for 3,500,000 series A preferred shares from Thomas E. Ichim ( owner) for the price of $5,000 cash and 500,000 Entest Biomedical, Inc. series B preferred shares.